UNII GR686LBA74

SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM

Unique Ingredient Identifier GR686LBA74 is listed as a unspecified ingredient

• RN: 10140-65-5
• NCIT: C66545
• RXCUI: 236719

Dosage Forms

UNII GR686LBA74 SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM is commonly included in medications in the following forms.

Route	Dosage Form	Potency
ORAL	SUSPENSION	8 mg/1mL
IM - IV	INJECTABLE	4 %
IM - IV	INJECTION	ADJPH
IM - IV	POWDER, FOR INJECTION SOLUTION	4 %
INTRADERMAL	INJECTION	0.2 %
INTRALESIONAL	SUSPENSION, INJECTION	0.14 %
INTRAMUSCULAR	INJECTABLE	4 %
INTRAMUSCULAR	INJECTION	0.48 %W/V
INTRAMUSCULAR	POWDER, FOR INJECTION SOLUTION	1.75 %W/V
INTRAMUSCULAR	SUSPENSION, INJECTION	0.14 %W/V
INTRASYNOVIAL	SUSPENSION, INJECTION	0.14 %
INTRAVENOUS	INJECTABLE	200 MG/1VIAL
INTRAVENOUS	INJECTABLE	4 %
INTRAVENOUS	INJECTION	0.76 %
INTRAVENOUS	POWDER, FOR INJECTION SOLUTION	1.75 %
INTRAVENOUS	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	3.25 %
INTRAVENOUS	SOLUTION, INJECTION	1.88 MG/1ML
INTRAVENOUS	SOLUTION, INJECTION	0.11 %
IV(INFUSION)	INJECTION	NA
IV(INFUSION)	POWDER, FOR INJECTION SOLUTION	4 %
IV(INFUSION)	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	0.38 %
IV(INFUSION)	SOLUTION	0.013 %
NASAL	SOLUTION, SPRAY	0.65 %
NASAL	SPRAY	352.09 MCG/SPRAY
NASAL	SPRAY	ADJPH
NASAL	SPRAY, METERED	0.3 %
OPHTHALMIC	SOLUTION	0.51 %
OPHTHALMIC	SUSPENSION	0.43 %
ORAL	CONCENTRATE	17 MG/5ML
ORAL	SOLUTION	140 MG/5ML
ORAL	SOLUTION, LIQUID	1.5 MG/1ML
ORAL	SUSPENSION	4.5 MG/1ML
ORAL	SYRUP	3.5 MG/1GM
ORAL	TABLET, EXTENDED RELEASE	71.5 MG
ORAL	TABLET, UNCOATED, LOZENGE	31 MG
SOFT TISSUE	SUSPENSION, INJECTION	0.14 %
SUBCUTANEOUS	INJECTION	0.66 %
SUBCUTANEOUS	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	0.3 %
SUBCUTANEOUS	SUSPENSION, INJECTION	0.09 %
TOPICAL	EMULSION, CREAM	0.1 %W/W
TOPICAL	OINTMENT	0.026 %W/W
TOPICAL	SOLUTION	0.51 %W/V
TRANSMUCOSAL	TABLET, UNCOATED, LOZENGE	28 MG